Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses

Journal of Virology

Volumn 75, Issue 20, 2001, Pages 9713-9722

  Guerrero, R A ^a   Ball, J M ^a   Krater, S S ^a   Pacheco, S E ^a   Clements, J D ^a   Estes, M K ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; KEYHOLE LIMPET HEMOCYANIN; OVALBUMIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; NORWALK GASTROENTERITIS VIRUS; PRIORITY JOURNAL; VAGINA; VIRUS PARTICLE; VIRUS RECOMBINANT;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, VIRAL; BACTERIAL TOXINS; CALICIVIRIDAE INFECTIONS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENTEROTOXINS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FECES; FEMALE; GASTROENTERITIS; HEMOCYANIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; NORWALK VIRUS; OVALBUMIN; VACCINATION; VAGINA; VIRAL VACCINES; VIRION;

EID: 0034802009     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.20.9713-9722.2001     Document Type: Article

References (38)

1. Nasal delivery of vaccines
2. Recombinant Norwalk virus-like particles given orally to volunteers: Phase I study
3. Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice
4. Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions
5. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina
6. LT(R192G), a non-toxic mutant of the heat-labile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp.
7. Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity
8. The molecular biology of caliciviruses
9. Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens
10. A comparison of natural and recombinant cholera toxin B subunit as stimulatory factors in intranasal immunization
11. Induction of a secretory IgA response in the murine female urogenital tract by immunization of the lungs with liposome-supplemented viral subunit antigen
12. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity
13. Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant
14. Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin
15. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants
16. Norwalk virus vaccines: Challenges and progress
17. Molecular epidemiology of "Norwalk-like viruses" in outbreaks of gastroenteritis in the United States
18. Bacterial toxins as mucosal adjuvants
19. Norwalk virus infection of volunteers: New insights based on improved assays
20. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces
21. Mucosal immunity: Implications for vaccine development
22. Norwalk virus genome cloning and characterization
23. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein
24. Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates
25. Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis
26. Sequence and genome organization of a human small round-structured (Norwalk-like) virus
27. The common mucosal immune system and current strategies for induction of immune responses in external secretions
28. Effectiveness of intranasal immunization with HIV-gp160 and an HIV-1 env CTL epitope peptide (E7) in combination with the mucosal adjuvant LT(R192G)
29. Rotavirus 2/6 viruslike particles administered intranasally with cholera toxin, Escherichia coli heat-labile toxin (LT), and LT-R192G induce protection from rotavirus challenge
30. Rotavirus virus-like particles administered mucosally induce protective immunity
31. Current view of NALT, LALT, and BALT in humans
32. Intranasal immunization with HIV reverse transcriptase: Effect of dose in the induction of helper T cell type 1 and 2 immunity
33. X-ray crystallographic structure of the Norwalk virus capsid
34. Drug delivery takes a deep breath
35. Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin
36. The incidence and genetic variabillty of small round-structured viruses in outbreaks of gastroenteritis in The Netherlands
37. Attachment and entry of recombinant Norwalk virus capsids to cultured human and animal cell lines
38. Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system